Jonathan Wan – Academic Clinical Fellow

Research articles

• Genome-wide mutational signatures in low-coverage whole genome sequencing of cell-free DNA (2022). JCM Wan et al. Nature Communications
  • Blog post: Behind the paper – Identifying mutational signatures in circulating cell-free DNA. Nature Portfolio Cancer Community
  • Patent: WO2023278524A1
    
• ctDNA monitoring using patient-specific sequencing and integration of variant reads (2020). JCM Wan*, Heider* et al. Science Translational Medicine
  • Explainer: Cancer treatment: personalised blood tests can better detect DNA from tumours in the body – new research. The Conversation
  • Patent: WO2019170773A1
  • Media: The Telegraph / Independent / The Times / Daily Mail
    
• Detection of ctDNA from dried blood spots after DNA size selection (2020). Heider*, JCM Wan* et al. Clinical Chemistry
  • Patent: US20220017891A1 
    

Reviews

• Leveraging circulating microbial DNA for early cancer detection (2023). Kataria, Shoaie, Grigoriadis, JCM Wan. Trends in Cancer
  
• Liquid biopsies for residual disease and recurrence (2021). JCM Wan et al. Med
  
• Next-Generation Liquid Biopsies: Embracing Data Science in Oncology (2021). Im, Tsui, Diaz, JCM Wan. Trends in Cancer
  
• Liquid biopsies come of age: towards implementation of circulating tumour DNA (2017). JCM Wan et al. Nature Reviews Cancer
  

Magazine articles

• Liquid biopsies – Innovation and Revolution (2023). JCM Wan. PGS OPUS
  

Full list available on Google Scholar